ADM and Asahi Group Forge Global Distribution Deal for Clinically Backed Postbiotic Supporting Stress, Mood & Sleep
Thursday, July 17th, 2025
ADM has partnered with Japan’s Asahi Group Foods to exclusively distribute a clinically backed postbiotic, Lactobacillus gasseri CP2305, across Asia, Europe, and North America, tapping into growing demand for functional food ingredients that support stress relief, mood balance, and sleep health.
ADM has signed an exclusive distribution agreement with Asahi Group Foods Corporation to bring Lactobacillus gasseri CP2305, a clinically studied, lactic acid-based postbiotic, to food manufacturers across Asia, Europe, and North America. The partnership marks a strategic expansion of ADM’s microbiome solutions portfolio, aiming to meet rising consumer demand for functional ingredients that support emotional well-being and sleep quality.
Backed by eight gold-standard human clinical trials, CP2305 has demonstrated benefits in reducing stress, improving sleep efficiency, and supporting overall emotional balance. The postbiotic, originally developed by Asahi through its proprietary research on Calpis-derived lactic acid bacteria, is already used in supplements and beverages in Japan. Through this agreement, ADM will now make CP2305 available for broader food and beverage innovation globally.
“Stress, mood, and sleep are among the fastest-growing wellness segments. With CP2305, we’re adding a proven, resilient postbiotic to our health and wellness toolkit, enabling food manufacturers to meet evolving consumer expectations,” said Mark Lotsch, President of Global Health & Wellness at ADM.
ADM noted that products targeting relaxation and mood support grew at a CAGR of 13% globally from 2018 to 2023, with category sales increasing by nearly 34% during the same period. The timing aligns with strong growth in functional snacks and beverages across Asia-Pacific — particularly those designed to promote better mental well-being and restorative sleep.
The postbiotic’s formulation stability also opens up innovation opportunities in high-heat or high-moisture applications, including gummies and ready-to-drink formats, increasingly popular delivery methods for health-conscious consumers in the region.
Postbiotics, the bioactive compounds produced during fermentation by probiotics, represent an emerging category in functional ingredients. Unlike live probiotics, postbiotics are heat-stable and do not require refrigeration, making them ideal for use in a broader range of food and beverage applications. Their stability allows manufacturers to overcome formulation challenges associated with live cultures, while still delivering scientifically validated health benefits. For Asia-Pacific brands exploring functional snacks, ready-to-drink beverages, or gummies, postbiotics like L. gasseri CP2305 offer a compelling route to meet wellness demands without compromising shelf life or production efficiency.
“Asahi is committed to solving global food and health challenges. This partnership allows us to extend CP2305’s benefits to new markets through ADM’s strong commercial and R&D networks,” said Kazuhiro Hayashi, Corporate Officer at Asahi Group Foods.
The move signals continued momentum in the functional ingredients sector as Asia’s food and beverage producers explore new ways to deliver science-backed wellness solutions. ADM’s distribution of CP2305 is expected to begin in Asia from March 2026.
Check out our latest ebook. Stay in touch with APFI for updates in the ASEAN food manufacturing space and more via our weekly newsletter! Sign up here.
SHARE WITH FRIENDS:
TAGS:












